FunPep Co's Total Assets for the quarter that ended in Dec. 2025 was 円1,980.86 Mil.
During the past 12 months, FunPep Co's average Total Assets Growth Rate was -72.20% per year.
During the past 3 years, the average Total Assets Growth Rate was -34.30% per year.
During the past 5 years, the average Total Assets Growth Rate was 18.00% per year.
During the past 9 years, FunPep Co's highest 3-Year average Total Assets Growth Rate was 88.60%. The lowest was -34.30%. And the median was 33.10%.
Total Assets is connected with ROA %. FunPep Co's annualizedROA % for the quarter that ended in Dec. 2025 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. FunPep Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
FunPep Co's Asset Turnover for the quarter that ended in Dec. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
FunPep Co Total Assets Related Terms
FunPep Co Total Assets Historical Data
* Premium members only.
The historical data trend for FunPep Co's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
FunPep Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FunPep Co (TSE:4881) has a Total Assets of 円1,980.86 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on FunPep Co and its competitors.
Is FunPep Co's Total Assets too high?
FunPep Co's current Total Assets is 円1,980.86 Mil. Overall, FunPep Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does FunPep Co's Total Assets compare to VRTX and REGN?
FunPep Co's Total Assets of 円1,980.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on FunPep Co and its competitors. FunPep Co's current Total Assets is 円1,980.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FunPep Co stock overvalued right now?
Based on GuruFocus' analysis, FunPep Co (TSE:4881) is currently considered Significantly Overvalued. The stock's GF Value™ is 円27.37, compared to a current price of 円70.00 — trading 155.8% above its estimated fair value. The current Total Assets is 円1,980.86 Mil. FunPep Co's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For FunPep Co (TSE:4881), the current Total Assets is 円1,980.86 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is FunPep Co (TSE:4881) Overvalued in 2026?
Based on GuruFocus' analysis, FunPep Co stock appears to be overvalued.
The current stock price of 円70.00 is trading 155.8% above its estimated GF Value™ of 円27.37.
GuruFocus considers FunPep Co to be Significantly Overvalued.
Key valuation signals for TSE:4881:
Total Assets: 円1,980.86 Mil
GF Value™: 円27.37 vs. price of 円70.00 (155.8% above fair value)
No single metric tells the full story. See the TSE:4881 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
FunPep Co Ltd is a biotechnology company focused on the functions of peptides to develop business from cosmetics to medical devices and pharmaceutical products. The company develops drugs related to the intractable peptic ulcer disease. The Group operates in a single segment, which is the research and development of pharmaceuticals.
46GF Score
Get the complete analysis for TSE:4881
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4881 has been successfully added to your 
